Status:
COMPLETED
Pregabalin Versus Celecoxib on Sevoflurane and Analgesic Consumption in Spine Fixation Surgery
Lead Sponsor:
South Egypt Cancer Institute
Conditions:
Post-Operative Pain
Eligibility:
All Genders
21-60 years
Phase:
PHASE2
PHASE3
Brief Summary
The anti-epileptic drugs such as gabapentin and other non-steroidal anti-inflammatory drugs (NSAID) such as celecoxib were used as a part of multimodal analgesia to control such pain. Gabapentin is an...
Eligibility Criteria
Inclusion
- American society of anesthesiologists (ASA) I and II, aged between 21-60 years old scheduled to undergo elective posterior approach lumbar spine disc surgery
Exclusion
- Patients with a known sensitivity to celecoxib or pregabalin, psychotic disorder or cognitive impairment, history of drug dependency or substance addiction, history of chronic medical disease, the presence of coagulation disorders or pregnancy, were excluded from the study.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04342065
Start Date
January 1 2019
End Date
February 1 2020
Last Update
April 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Egypt Cancer Institute, Assiut University, Arab Republic of Egypt
Asyut, Egypt, 0020